A business in context
KYMR research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-24 | Albers Jeffrey W. | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
| 2026-06-24 | Sandor Victor | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
| 2026-06-24 | Esposito Pamela | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
| 2026-06-24 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | A · Grant / award | Non-Qualified Stock Option (right to buy) | 6068.0 | 0.0 |
| 2026-06-24 | 667, L.P.; BAKER BROS. ADVISORS LP; BAKER FELIX; BAKER JULIAN; Baker Bros. Advisors (GP) LLC; Baker Brothers Life Sciences LP | A · Grant / award | Non-Qualified Stock Option (right to buy) | 6068.0 | 0.0 |
| 2026-06-24 | BIOTECHNOLOGY VALUE FUND II LP; BIOTECHNOLOGY VALUE FUND L P; BVF GP HOLDINGS LLC; BVF I GP LLC; BVF II GP LLC; BVF INC/IL; BVF PARTNERS L P/IL; BVF Partners OS Ltd.; Biotechnology Value Trading Fund OS LP; LAMPERT MARK N | A · Grant / award | Stock Option (Right to Buy) | 6068.0 | 0.0 |
| 2026-06-23 | Booth Bruce | S · Sale | Common Stock | 1235.0 | 99.98 |
| 2026-06-23 | Booth Bruce | S · Sale | Common Stock | 173.0 | 99.98 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 1341.0 | 104.38 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 2560.0 | 103.42 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 18313.0 | 103.42 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 9584.0 | 104.38 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 14921.0 | 92.14 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 2035.0 | 94.48 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 11783.0 | 95.12 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 20903.0 | 96.24 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 16084.0 | 97.68 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 25976.0 | 98.58 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 52442.0 | 99.57 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 56348.0 | 100.17 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 6597.0 | 101.61 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 8990.0 | 102.48 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 2179.0 | 92.14 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 286.0 | 94.48 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 1648.0 | 95.12 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 2919.0 | 96.24 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 2247.0 | 97.68 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 3603.0 | 98.58 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 7319.0 | 99.57 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 7879.0 | 100.17 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 918.0 | 101.61 |
| 2026-06-22 | Booth Bruce | S · Sale | Common Stock | 1253.0 | 102.48 |
| 2026-06-22 | Goodman Noah | M · Exercise / conversion | Common Stock | 2500.0 | 21.05 |
| 2026-06-22 | Goodman Noah | S · Sale | Common Stock | 2500.0 | 99.0 |
| 2026-06-22 | Goodman Noah | M · Exercise / conversion | Stock Option (Right to Buy) | 2500.0 | 0.0 |
| 2026-06-18 | Booth Bruce | S · Sale | Common Stock | 5672.0 | 92.16 |
| 2026-06-18 | Booth Bruce | S · Sale | Common Stock | 32359.0 | 91.85 |
| 2026-06-18 | Booth Bruce | S · Sale | Common Stock | 4526.0 | 91.85 |
| 2026-06-18 | Booth Bruce | S · Sale | Common Stock | 793.0 | 92.16 |
| 2026-06-18 | Booth Bruce | S · Sale | Common Stock | 8809.0 | 90.48 |
| 2026-06-18 | Booth Bruce | S · Sale | Common Stock | 62897.0 | 90.48 |
| 2026-06-17 | Booth Bruce | S · Sale | Common Stock | 12902.0 | 90.38 |
| 2026-06-17 | Booth Bruce | S · Sale | Common Stock | 92169.0 | 90.38 |
| 2026-06-17 | Booth Bruce | S · Sale | Common Stock | 11741.0 | 89.98 |
| 2026-06-17 | Booth Bruce | M · Exercise / conversion | Common Stock | 11741.0 | 20.0 |
| 2026-06-17 | Booth Bruce | M · Exercise / conversion | Stock Option (Right to Buy) | 11741.0 | 0.0 |
| 2026-06-02 | Jacobs Bruce N. | M · Exercise / conversion | Common Stock | 12653.0 | 2.08 |
| 2026-06-02 | Jacobs Bruce N. | M · Exercise / conversion | Stock Option (Right to Buy) | 12653.0 | 0.0 |
| 2026-05-27 | Chadwick Jeremy G | S · Sale | Common Stock | 600.0 | 82.08 |
| 2026-05-27 | Chadwick Jeremy G | S · Sale | Common Stock | 3679.0 | 81.5 |
Identity & relationships
SEC issuer · 0001815442Kymera Therapeutics, Inc.
Search names and former names
View Wikidata identity and references ↗
- Kymera Therapeutics · alias · wikidata
- Kymera Therapeutics, Inc. · former SEC name · 2020-06-22 to 2026-09-04
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $47.07M | $50.11M |
| 2023-12-31 | $78.59M | $86.12M |
| 2022-12-31 | $46.83M | $53.42M |
| 2021-12-31 | $72.83M | $89.74M |
| 2020-12-31 | $34.03M | $43.91M |
| 2019-12-31 | $2.93M | $3.83M |